LPL Financial LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm purchased 57,487 shares of the medical instruments supplier’s stock, valued at approximately $1,830,000.
Other hedge funds have also recently made changes to their positions in the company. Ellevest Inc. grew its position in shares of DENTSPLY SIRONA by 281.2% during the 3rd quarter. Ellevest Inc. now owns 1,216 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 897 shares in the last quarter. Eisler Capital UK Ltd. purchased a new position in DENTSPLY SIRONA in the third quarter worth $45,000. Parkside Financial Bank & Trust grew its position in DENTSPLY SIRONA by 163.7% in the first quarter. Parkside Financial Bank & Trust now owns 915 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 568 shares in the last quarter. Signaturefd LLC grew its position in DENTSPLY SIRONA by 20.8% in the fourth quarter. Signaturefd LLC now owns 1,973 shares of the medical instruments supplier’s stock worth $63,000 after acquiring an additional 340 shares in the last quarter. Finally, Neo Ivy Capital Management grew its position in DENTSPLY SIRONA by 117.4% in the third quarter. Neo Ivy Capital Management now owns 4,196 shares of the medical instruments supplier’s stock worth $119,000 after acquiring an additional 2,266 shares in the last quarter. 98.52% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts recently issued reports on XRAY shares. UBS Group upped their target price on shares of DENTSPLY SIRONA from $43.00 to $46.00 in a research report on Friday, May 5th. Barrington Research boosted their price target on shares of DENTSPLY SIRONA from $43.00 to $51.00 in a research note on Thursday, May 4th. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $29.00 to $35.00 and gave the stock a “neutral” rating in a research note on Monday, February 6th. TheStreet raised shares of DENTSPLY SIRONA from a “d+” rating to a “c” rating in a research note on Tuesday, February 28th. Finally, Stifel Nicolaus boosted their price target on shares of DENTSPLY SIRONA from $37.00 to $41.00 in a research note on Thursday, May 4th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and an average price target of $42.13.
DENTSPLY SIRONA Stock Down 3.5 %
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its quarterly earnings data on Wednesday, May 3rd. The medical instruments supplier reported $0.39 EPS for the quarter, beating the consensus estimate of $0.34 by $0.05. The firm had revenue of $978.00 million during the quarter, compared to the consensus estimate of $938.16 million. DENTSPLY SIRONA had a negative net margin of 26.41% and a positive return on equity of 8.65%. The company’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.52 earnings per share. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.91 earnings per share for the current year.
DENTSPLY SIRONA Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, April 14th. Investors of record on Friday, March 31st were given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.31%. The ex-dividend date of this dividend was Thursday, March 30th.
Insider Activity at DENTSPLY SIRONA
In related news, SVP Cord Friedrich Staehler sold 4,000 shares of the business’s stock in a transaction dated Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total transaction of $157,320.00. Following the transaction, the senior vice president now owns 97,693 shares in the company, valued at $3,842,265.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, SVP Cord Friedrich Staehler sold 4,000 shares of the business’s stock in a transaction dated Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total transaction of $157,320.00. Following the transaction, the senior vice president now owns 97,693 shares in the company, valued at $3,842,265.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Eric Brandt sold 6,200 shares of the business’s stock in a transaction dated Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total transaction of $261,454.00. Following the transaction, the director now owns 44,902 shares in the company, valued at approximately $1,893,517.34. The disclosure for this sale can be found here. 0.76% of the stock is owned by corporate insiders.
About DENTSPLY SIRONA
Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.
Recommended Stories
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.